11 January 2013

Bayer approved to buy Teva Animal Drug Division

Bayer HealthCare announced last week it has completed the purchase of Teva Pharmaceutical Industries following regulatory approval from the U.S. Federal Trade Commission.

The $145 million purchase, announced in September 2012, will include Teva's animal health manufacturing site in St. Joseph, which employs about 300. 




No comments:

Post a Comment